REC Interventional Cardiology最新文献

筛选
英文 中文
Debate: TAVI prosthesis selection for severe calcification. The self-expandable technology approach. 争论:严重钙化的TAVI假体选择。自扩展技术方法。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-05-16 eCollection Date: 2025-01-01 DOI: 10.24875/RECICE.M25000515
Raquel Del Valle Fernández
{"title":"Debate: TAVI prosthesis selection for severe calcification. The self-expandable technology approach.","authors":"Raquel Del Valle Fernández","doi":"10.24875/RECICE.M25000515","DOIUrl":"10.24875/RECICE.M25000515","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 3","pages":"181-183"},"PeriodicalIF":1.5,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fast-track TAVI: establishing a new standard of care. 快速推进TAVI:建立新的护理标准。
IF 1.1
REC Interventional Cardiology Pub Date : 2025-05-16 eCollection Date: 2025-01-01 DOI: 10.24875/RECIC.M25000515
Lluís Asmarats, Dabit Arzamendi
{"title":"Fast-track TAVI: establishing a new standard of care.","authors":"Lluís Asmarats, Dabit Arzamendi","doi":"10.24875/RECIC.M25000515","DOIUrl":"10.24875/RECIC.M25000515","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 3","pages":"138-139"},"PeriodicalIF":1.1,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145016379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter closure of multiperforated atrial septal defect. 经导管闭合术治疗房间隔多孔缺损。
IF 1.1
REC Interventional Cardiology Pub Date : 2025-05-05 eCollection Date: 2025-01-01 DOI: 10.24875/RECICE.M25000510
Luis Cerdán Ferreira, Georgina Fuertes Ferre, Juan Sánchez-Rubio Lezcano, Marta López Ramón
{"title":"Transcatheter closure of multiperforated atrial septal defect.","authors":"Luis Cerdán Ferreira, Georgina Fuertes Ferre, Juan Sánchez-Rubio Lezcano, Marta López Ramón","doi":"10.24875/RECICE.M25000510","DOIUrl":"10.24875/RECICE.M25000510","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Multi-fenestrated atrial septal defects (mASD) pose both diagnostic and therapeutic challenges. This study aimed to compare the outcomes of transcatheter closure in patients with mASD vs those with a single ASD at our center.</p><p><strong>Methods: </strong>We conducted a retrospective, single-center study including adult patients who underwent transcatheter ASD closure from October 2014 through October 2024. Demographic, echocardiographic, and hemodynamic data were collected, with a the 6-month follow-up.</p><p><strong>Results: </strong>A total of 67 patients were included, 12 of whom (18%) exhibited mASD. Patients with mASD were younger (42 vs 54 years) and more frequently presented with an interatrial septal aneurysm (91% vs 27%; P = .001). The use of multiple occlusion devices was more common in patients with mASD (34% vs 4%; P = .008). Complications were rare (5.9%) and none occurred in the mASD group. Procedural outcomes, including residual shunt and right ventricular remodeling at the follow-up, were comparable between groups.</p><p><strong>Conclusions: </strong>Transcatheter closure of mASD is both a safe and feasible procedure, with clinical outcomes similar to those observed in patients with a single ASD.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 3","pages":"164-168"},"PeriodicalIF":1.1,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of ultrasound renal denervation reducing blood pressure: a systematic review and meta-analysis. 超声肾去神经术降低血压的疗效:系统回顾和荟萃分析。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-04-29 eCollection Date: 2025-01-01 DOI: 10.24875/RECICE.M25000509
Juan Miguel Guerrero-Hernández, Cristian Jesús Palomino-Ojeda, Lissette Haydee García-Mena, José Luis Maldonado-García, Óscar Ángel Vedia-Cruz, José Antonio García-Donaire, Iván Javier Núñez-Gil
{"title":"Efficacy of ultrasound renal denervation reducing blood pressure: a systematic review and meta-analysis.","authors":"Juan Miguel Guerrero-Hernández, Cristian Jesús Palomino-Ojeda, Lissette Haydee García-Mena, José Luis Maldonado-García, Óscar Ángel Vedia-Cruz, José Antonio García-Donaire, Iván Javier Núñez-Gil","doi":"10.24875/RECICE.M25000509","DOIUrl":"10.24875/RECICE.M25000509","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Ultrasound renal denervation (uRDN) has emerged as an innovative therapeutic approach for the treatment of hypertension. However, its efficacy compared to medication remains uncertain. We aimed to assess the efficacy profile of uRDN vs sham groups focusing on its impact on daytime ambulatory blood pressure, 24-hour blood pressure, home blood pressure and office blood pressure.</p><p><strong>Methods: </strong>We conducted a systematic search across Embase, PubMed, and Cochrane Library databases from their inception up 1 November 2024 to identify randomized controlled trials evaluating the efficacy of uRDN. Statistical analyses were performed using RevMan 6.3 software, utilizing the mean and standard deviation method to calculate mean differences with a 95% confidence interval (95%CI).</p><p><strong>Results: </strong>A total of 4 studies were included in the final analysis with 642 patients. uRDN significantly reduced daytime ambulatory systolic blood pressure (SBP) (-5.12 mmHg; 95%CI, -6.07 to -4.16; P ≤ .00001), 24-h SBP (-4.87 mmHg; 95%CI, -6.53 to -3.21]; P ≤ .00001), office SBP (-5.03 mmHg; 95%CI, -6.27 to -3.79; P ≤ .00001) and showed a decrease in patient medication 6 months after the procedure.</p><p><strong>Conclusions: </strong>Using uRDN leads to a lower blood pressure in patients within 2 months following the procedure. Additionally, after 6 months a significant decrease in drug use is observed.This meta-analysis protocol was registered on PROSPERO on 7 July 2024 (CRD42024562852).</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 3","pages":"154-163"},"PeriodicalIF":1.5,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early discharge following transcatheter aortic valve implantation: a feasible goal during the learning curve? 经导管主动脉瓣植入术后早期出院:学习曲线中可行的目标?
IF 1.5
REC Interventional Cardiology Pub Date : 2025-04-29 eCollection Date: 2025-01-01 DOI: 10.24875/RECICE.M25000508
Raquel Pimienta González, Alejandro Quijada Fumero, Marcos Farráis Villalba, Javier Lorenzo González, Ana Laynez Carnicero, Alejandro Iriarte Plasencia, Gabriela Noemí González Chiale, Cristina López Ferraz, Juan Manuel Llanos Gómez, Martín Caicoya Boto, Ángel López Castillo, Julio Salvador Hernández Afonso
{"title":"Early discharge following transcatheter aortic valve implantation: a feasible goal during the learning curve?","authors":"Raquel Pimienta González, Alejandro Quijada Fumero, Marcos Farráis Villalba, Javier Lorenzo González, Ana Laynez Carnicero, Alejandro Iriarte Plasencia, Gabriela Noemí González Chiale, Cristina López Ferraz, Juan Manuel Llanos Gómez, Martín Caicoya Boto, Ángel López Castillo, Julio Salvador Hernández Afonso","doi":"10.24875/RECICE.M25000508","DOIUrl":"10.24875/RECICE.M25000508","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Although early discharge protocols after transcatheter aortic valve implantation (TAVI) have demonstrated to be safe in various studies, they are usually applied in high-experience centers. This study analyzes the length of stay of the first 100 patients undergoing TAVI in a center without on-site cardiac surgery, differentiating between very early (< 24 hours), early (24-48 hours), and late discharge (> 48 hours). Furthermore, the study evaluates the feasibility of an early discharge protocol during the team's learning curve.</p><p><strong>Methods: </strong>We conducted a prospective observational study from April 2022 through January 2024. A pre- and postoperative management protocol was implemented, including assessments in the Valvular Heart Disease Clinic, admission to the cardiac surgery intensive care unit with electrocardiographic monitoring, and specific discharge criteria in full compliance with an established protocol for the management of conduction disorders. Early follow-up evaluations were performed in the outpatiently after discharge.</p><p><strong>Results: </strong>A total of 100 patients (50% women) were included, with a mean age of 82.4 ± 5.3 years and a EuroSCORE II score of 4.38 ± 5.1%. The median length of stay was 2 days (range, 1-19). A total of 27.27% of patients were discharged in < 24 hours, 48.49% within the 24-48 hours following implantation, and 24.24% 48 hours later. The 30-day cardiovascular mortality rate was 1%. A total of 6 patients were readmitted with procedural complications within the first 30 days.</p><p><strong>Conclusions: </strong>The implementation of a standardized care protocol allows for early and safe discharge in most patients, even during the team's learning cuve.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 3","pages":"146-153"},"PeriodicalIF":1.5,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous congestion in a d-TGA patient after Mustard procedure. 芥子气手术后d-TGA患者的静脉充血。
IF 1.1
REC Interventional Cardiology Pub Date : 2025-04-12 eCollection Date: 2025-01-01 DOI: 10.24875/RECICE.M25000500
Francisco Javier Ruperti-Repilado, Félix Coserria-Sánchez, Amadeo Wals-Rodríguez, Agustín Guisado, José Díaz-Fernández, Pastora Gallego
{"title":"Venous congestion in a d-TGA patient after Mustard procedure.","authors":"Francisco Javier Ruperti-Repilado, Félix Coserria-Sánchez, Amadeo Wals-Rodríguez, Agustín Guisado, José Díaz-Fernández, Pastora Gallego","doi":"10.24875/RECICE.M25000500","DOIUrl":"10.24875/RECICE.M25000500","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 3","pages":"193-194"},"PeriodicalIF":1.1,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis. 【必要的紫杉醇原药物洗脱球囊治疗支架内再狭窄的延长随访】。
IF 1.1
REC Interventional Cardiology Pub Date : 2025-04-07 eCollection Date: 2025-04-01 DOI: 10.24875/RECICE.M25000502
Lucio Padilla, Jorge Tello, Pablo Lamelas
{"title":"Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis.","authors":"Lucio Padilla, Jorge Tello, Pablo Lamelas","doi":"10.24875/RECICE.M25000502","DOIUrl":"10.24875/RECICE.M25000502","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 2","pages":"130-131"},"PeriodicalIF":1.1,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary protection in TAVI: use of the guide catheter extension system. TAVI中的冠状动脉保护:导管延伸系统的应用。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-04-07 eCollection Date: 2025-10-01 DOI: 10.24875/RECICE.M25000504
Georgina Fuertes Ferre, Juan Sánchez Rubio, María Cruz Ferrer Gracia, José Antonio Diarte de Miguel
{"title":"Coronary protection in TAVI: use of the guide catheter extension system.","authors":"Georgina Fuertes Ferre, Juan Sánchez Rubio, María Cruz Ferrer Gracia, José Antonio Diarte de Miguel","doi":"10.24875/RECICE.M25000504","DOIUrl":"10.24875/RECICE.M25000504","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"276-277"},"PeriodicalIF":1.5,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clover sign. A predictor of optimal plaque modification after orbital atherectomy. 三叶草标志。眼眶动脉粥样硬化切除术后最佳斑块修饰的预测因子。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-04-07 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000506
Jon Zubiaur, Ariana Gonzálvez-García, Santiago Jiménez-Valero, Guillermo Galeote-García, Raúl Moreno, Alfonso Jurado-Román
{"title":"The clover sign. A predictor of optimal plaque modification after orbital atherectomy.","authors":"Jon Zubiaur, Ariana Gonzálvez-García, Santiago Jiménez-Valero, Guillermo Galeote-García, Raúl Moreno, Alfonso Jurado-Román","doi":"10.24875/RECICE.M25000506","DOIUrl":"10.24875/RECICE.M25000506","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 1","pages":"60-61"},"PeriodicalIF":1.5,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chiari network. A potential enemy in patent foramen ovale closure. 网络。卵圆孔未闭闭合的潜在敌人。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-03-26 eCollection Date: 2025-10-01 DOI: 10.24875/RECICE.M25000505
Yassin Belahnech, Gerard Martí-Aguasca, Bruno García Del Blanco
{"title":"Chiari network. A potential enemy in patent foramen ovale closure.","authors":"Yassin Belahnech, Gerard Martí-Aguasca, Bruno García Del Blanco","doi":"10.24875/RECICE.M25000505","DOIUrl":"10.24875/RECICE.M25000505","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"278-279"},"PeriodicalIF":1.5,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书